|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1A
|
|
pubmed:dateCreated |
2002-5-17
|
|
pubmed:abstractText |
Urokinase type plasminogen activator receptor (uPAR) plays an important role in cancer invasion and metastasis. However, the uPAR expression has been rarely investigated in thyroid carcinomas. The aim of this study was to evaluate the clinical relevance of uPAR in thyroid tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
387-93
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:12017319-Adenocarcinoma, Follicular,
pubmed-meshheading:12017319-Adenoma,
pubmed-meshheading:12017319-Adolescent,
pubmed-meshheading:12017319-Adult,
pubmed-meshheading:12017319-Aged,
pubmed-meshheading:12017319-Disease-Free Survival,
pubmed-meshheading:12017319-Female,
pubmed-meshheading:12017319-Humans,
pubmed-meshheading:12017319-Immunohistochemistry,
pubmed-meshheading:12017319-Male,
pubmed-meshheading:12017319-Middle Aged,
pubmed-meshheading:12017319-Neoplasm Metastasis,
pubmed-meshheading:12017319-Receptors, Cell Surface,
pubmed-meshheading:12017319-Receptors, Urokinase Plasminogen Activator,
pubmed-meshheading:12017319-Thyroid Diseases,
pubmed-meshheading:12017319-Thyroid Neoplasms
|
|
pubmed:articleTitle |
uPA receptor expression in benign and malignant thyroid tumors.
|
|
pubmed:affiliation |
Department of Surgical Oncology, Osaka University Medical School, Suita City, Japan. kimsj@onsurg.med.osaka-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
